Description: Cayman is a rapidly growing reinsurance domicile with several notable transactions executed in the past few years. We expect this trend to persist as (re)insurers will continue to explore more effective ways to manage their business. In this session, you will gain: - An overview of how the Cayman (re)insurance market has developed over recent years - An introduction to the Cayman regulatory framework - Key considerations for reinsurance structuring and pricing. Join a discussion at the close of the session on the outlook for the Cayman market. You will leave this session with an understanding of the Cayman (re)insurance market, the regulatory framework and key factors that impact reinsurance structuring and pricing.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: ClubVita Session Series Longevity trend risk still exists even for the largest portfolios. Explore the differences in longevity improvements between different populations, how to categorize subpopulations with different trend risk characteristics, and how to use this categorization to reduce longevity trend basis risk.

Description: Learn about considerations and industry observed trends which cover different ways companies try to manage their inforce business in low and rapidly rising interest environments. You will explore M&A, block transaction, and offshore reinsurance solutions.

Description: The surge in interest rates over the past few years presents opportunities for life insurers to enhance their Asset and Liability Management (ALM) positions through asset rebalancing to narrow the duration gap and secure higher risk-adjusted yields. This webcast introduces a robust, efficient and readily-executable, liability-driven strategic asset allocation (SAA) framework and implementation considerations. At the conclusion of the webcast, attendees will learn about the key objectives and practical considerations for a successful SAA.

Description: A lot is happening in the annuity industry. The presenters will provide an overview of key developments in annuities and their implications to product actuaries. They will discuss recent product and market trends in fixed, indexed and variable annuities. They will also explore emerging regulatory requirements affecting annuities, such as VM-22 and Best Interest rules, as well as how they may impact product development. - Learn about recent product and market trends in annuities - Be informed of key emerging regulatory developments affecting annuities - Understand how these developments may affect product development

Description: Retirement planning generally includes a focus on decisions needed at time of retirement, but it often fails to focus on changes during retirement and additional decisions needed as people age. The 2021 SOA Risk Survey and other SOA research documents the lack of focus on future change. It is common for people to lose cognitive ability and generally to become less able to make decisions, manage their finances, their medical care and their lives at high ages.This panel focuses on communication and decision issues. The SOA has recently issued a decision guide on High Age Decisions. The brief identifies four domains for high age decisions: ·Health, health care and staying healthy ·Managing finances ·Housing and transportation ·Support networks The panel will include a discussion of communications and how we change, problems of physical, hearing, sight or cognitive decline and the challenges created and the four domains in the SOA Decision Brief.

Description: "On the decomposition of mortality models into causes of death – Andrés M Villegas Ph.D – UNSW Australia, Madhavi Bajekal, Ph.D.,HONFIA, University of London, UK, Steven Haberman, Ph.D. – Bayes Business School, University of London, UK Forecasting cause-specific mortality rates using the insights from the cointegration analysis, Séverine Arnold, PhD, Viktoriya Glushko, Department of Actuarial Science, Faculty of Business and Economics (HEC Lausanne), University of Lausanne, Switzerland"

Description: Some research implies that micro SDOH-related risk factors can influence a significant proportion of an individual's overall health outcome. Contained in SDOH are items such as mental health, ongoing social connection and interactions, transportation, financial confidence, and other items.

Description: General Session III – The Ageing Process: From New Technology to New Medicine